Renavel 800mg Tablets are a crucial treatment option designed specifically for individuals with chronic kidney disease (CKD) undergoing dialysis. Formulated with sevelamer hydrochloride, these tablets serve as a powerful non-absorbable phosphate binder that effectively addresses hyperphosphatemia, a common complication in CKD patients. By significantly reducing phosphate absorption from dietary sources, Renavel Tablets help maintain balanced phosphate levels in the bloodstream, which is vital for preventing serious complications such as bone disorders and vascular calcification.

The innovative mechanism of action of sevelamer hydrochloride allows Renavel Tablets to bind dietary phosphate within the gastrointestinal tract, preventing excess phosphate from entering the bloodstream. Unlike traditional calcium-based phosphate binders, Renavel does not contribute to elevated serum calcium levels, thereby minimizing the risk of hypercalcemia and its associated complications. This makes Renavel Tablets an ideal choice for patients seeking a safe and effective way to manage their phosphate levels.

Renavel Tablets are specifically tailored for patients on hemodialysis or peritoneal dialysis, forming an essential part of a comprehensive treatment plan. By effectively controlling hyperphosphatemia, these tablets help prevent secondary hyperparathyroidism and reduce the risk of cardiovascular disorders, ultimately promoting overall health and well-being.

For optimal effectiveness, it is recommended to take Renavel Tablets with meals, enhancing their phosphate-binding capabilities. Adhering to the dosage instructions provided by a healthcare professional is crucial, as the appropriate dosage may vary based on individual serum phosphate levels. To ensure proper absorption, the tablets should be swallowed whole and not crushed, chewed, or split.

Patients should exercise caution when using Renavel Tablets, especially those with gastrointestinal conditions such as dysphagia or bowel obstruction. This medication is not suitable for individuals with hypophosphatemia or those who have shown hypersensitivity to sevelamer hydrochloride. Regular monitoring of serum phosphate levels is necessary to confirm the ongoing effectiveness of the treatment.

While Renavel Tablets are generally well-tolerated, some individuals may experience common side effects, including nausea, vomiting, diarrhea, and constipation. In rare instances, patients may encounter abdominal pain or flatulence. Serious side effects, such as gastrointestinal obstruction or severe hypersensitivity reactions, require immediate consultation with a healthcare provider if any unusual symptoms arise.

It is also important to be aware of potential drug interactions, as Renavel Tablets may affect the absorption of certain medications. To maintain their efficacy, it is advisable to take these tablets separately from medications such as levothyroxine, ciprofloxacin, and anti-arrhythmic drugs.

Store Renavel Tablets at room temperature, between 15-30°C, in a dry place away from direct sunlight, and out of reach of children. A prescription is required to obtain this medication. For further inquiries or detailed information, please reach out to info@dermatologists.pk.